Advancements in Nasal Nano Delivery Systems for CNS Disorders

  • 624

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 16 January 2026 | Manuscript Submission Deadline 6 May 2026

  2. This Research Topic is currently accepting articles.

Background

Intranasal (IN) drug delivery is a safe, non-invasive method that offers significant advantages for the treatment of neurological and other central nervous system (CNS) diseases. This route enables both direct transport of therapeutics from the nasal cavity to the brain via olfactory and trigeminal pathways, effectively bypassing the blood-brain barrier, and indirect absorption into the systemic circulation. IN administration allows for rapid onset of action, reduced systemic side effects, and improved patient compliance compared to oral or intravenous routes.

It is particularly promising for delivering neuropeptides, monoclonal antibodies, and gene therapies, which often face challenges in crossing the blood-brain barrier. Recent research highlights the potential of IN delivery to enhance the efficacy and safety of CNS treatments. However, optimizing drug formulations and delivery devices remains essential to ensure consistent dosing and maximize therapeutic outcomes.

The goal of this Research Topic is to provide a comprehensive platform of Original Research, Review, and Perspective articles that collectively advance the field of nasal drug delivery systems with a particular focus on innovative nanoformulations, for treating CNS disorders. Additionally, it seeks to outline future directions for clinical translation, regulatory considerations, and interdisciplinary collaborations that will accelerate the development of nasal medications.

We welcome the submission of manuscripts including, but not limited to, the following topics. Special focus will be given (but is not restricted) to:

• Drugs used or potentially suitable for CNS disorders that may, due to physicochemical and pharmacokinetic challenges, benefit from nasal administration.

• Polymers used or potentially suitable for nasal nanoformulations.

• Nasal formulations designed for the treatment of CNS disorders.

• Regulatory considerations related to nasal formulations, with a particular focus on nanoformulations.

• Devices used or potentially suitable for targeted deposition of nanoformulations in the olfactory region.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Classification
  • Clinical Trial
  • Community Case Study
  • Curriculum, Instruction, and Pedagogy
  • Data Report
  • Editorial
  • FAIR² Data

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Regulatory aspect, Nasal administration, Nasal Delivery Systems, Nanoparticles, CNS disorders

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 624Topic views
View impact